Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 31 -40 of 49 Show results per page	View Search Criteria \| Help With Results


31.		Phase II Immunotherapy with High-Dose Intravenous Beta-Serine Interferon in Patients with Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								MSHMC-1670 NCI-V87-0247


32.		Phase II Immunotherapy with High-Dose Intravenous Beta-Serine Interferon in Patients with Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								YALE-HIC-4318 NCI-V87-0252

Last Modified: 5/1/1988


33.		Phase II Immunotherapy with High-Dose Intravenous Beta-Serine Interferon in Patients with Renal Cell Carcinoma (Summary Last Modified 05/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								AECM-8707167 NCI-V87-0256

Last Modified: 4/26/2007


34.		Phase II Randomized Study of IL-2/b-IFN vs IL-2 Alone in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 02/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				EST-5887 EST-5887

Last Modified: 3/1/1988


35.		Phase II Study of Recombinant IL-2/b-IFN in Patients with Advanced Malignant Melanoma (Summary Last Modified 03/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								FCCC-86796 NCI-V87-0285

Last Modified: 3/1/1988


36.		Phase II Study of Escalating Doses of Intravenous IFN-beta-ser in Patients with Malignant Glioma (Summary Last Modified 03/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 70								UAB-386 NCI-V87-0161

Last Modified: 5/1/1988


37.		Phase II Study of High-Dose Intravenous IFN-beta-ser in Patients with Malignant Glioma (Summary Last Modified 05/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 70								NYU-8720 NCI-V88-0350

Last Modified: 5/3/2006


38.		Phase II Study of 5-FU/B-IFN in Patients with Advanced Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				AECM-8902035 NCI-V89-0211

Last Modified: 12/5/2007


39.		Phase II Randomized Trial of IFN-B with and without 13-CRA in Patients with Recurrent Primary Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				16 and over				NCI				MDA-DM-92109 NCI-T92-0207C, T92-0207

Last Modified: 5/24/2008 First Published: 5/28/2004


40.		Phase II Study of Interferon beta in Patients With Metastatic Cutaneous or Ocular Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				CASE-CCF-4049 CCF-4049, CWRU-CASE-1604, NCT00085306

Select All on One Page


					< Previous 1 2 3 4 5 Next >

| | | | | | | |

A Service of the National Cancer Institute